Open AccessFrailty and Clinical Outcomes of Direct Oral Anticoagulants Versus Warfarin in Older Adults With Atrial Fibrillation
Author(s) -
Dae Kim,
Ajinkya Pawar,
Joshua J. Gagne,
Lily G. Bessette,
Hemin Lee,
Robert J. Glynn,
Sebastian Schneeweiß
Publication year - 2021
Publication title -
annals of internal medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.839
H-Index - 390
eISSN - 1539-3704
pISSN - 0003-4819
DOI - 10.7326/m20-7141
Subject(s) - medicine , rivaroxaban , dabigatran , warfarin , atrial fibrillation , hazard ratio , apixaban , cohort , stroke (engine) , cohort study , propensity score matching , proportional hazards model , cardiology , confidence interval , mechanical engineering , engineering
The role of differing levels of frailty in the choice of oral anticoagulants for older adults with atrial fibrillation (AF) is unclear.